Cite Filings / ACAD / 0000093751-26-000400

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

ACADIA PHARMACEUTICALS INC Filed 2026-08-07 Acc 0000093751-26-000400

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-10 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-07 4 EVP, CHIEF FINANCIAL OFFICER sold 20,141 shares at an average $29.16 ($587,242)
2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-05 144 Sale of Securities
2026-08-05 10-Q Quarterly Report
2026-08-04 8-K Results of operations
2026-04-28 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…